Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Lembke

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
The American Journal of Drug and Alcohol Abuse|August 29, 2012
Time to abandon the self-medication hypothesis in patients with psychiatric disordersAnna Lembke
Drug and Alcohol Review|November 26, 2013
Recovery-oriented policy and care systems in the UK and USAKeith Humphreys, Anna Lembke
Current Psychiatry Reports|December 2, 2005
Update on augmentation of antidepressant response in resistant depressionCharles DeBattista, Anna Lembke
Handbook of Clinical Neurology|October 14, 2014
Clinical management of alcohol use disorders in the neurology clinicAnna Lembke, Mark Stanford
Addiction Science & Clinical Practice|November 6, 2015
A qualitative study of treatment-seeking heroin users in contemporary ChinaAnna Lembke, Niushen Zhang
Tobacco Control|April 18, 2015
A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation researchAnna Lembke, Keith Humphreys
The American Journal of Psychiatry|February 2, 2002
Impaired recognition of facial emotion in maniaAnna Lembke, Terence A Ketter
Neuropsychiatric Disease and Treatment|March 21, 2009
Depression and smoking cessation: does the evidence support psychiatric practice?Anna Lembke, Kenasha Johnson, Charles DeBattista
American Family Physician|June 16, 2016
Weighing the Risks and Benefits of Chronic Opioid TherapyAnna Lembke, Keith Humphreys, Jordan Newmark
Journal of Addictive Diseases|March 30, 2021
Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case reportHuiqiong Deng, Ori-Michael Benhamou, Anna Lembke
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
The American Journal of Drug and Alcohol Abuse|August 29, 2012
Time to abandon the self-medication hypothesis in patients with psychiatric disordersAnna Lembke
Drug and Alcohol Review|November 26, 2013
Recovery-oriented policy and care systems in the UK and USAKeith Humphreys, Anna Lembke
Current Psychiatry Reports|December 2, 2005
Update on augmentation of antidepressant response in resistant depressionCharles DeBattista, Anna Lembke
Handbook of Clinical Neurology|October 14, 2014
Clinical management of alcohol use disorders in the neurology clinicAnna Lembke, Mark Stanford
Addiction Science & Clinical Practice|November 6, 2015
A qualitative study of treatment-seeking heroin users in contemporary ChinaAnna Lembke, Niushen Zhang
Tobacco Control|April 18, 2015
A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation researchAnna Lembke, Keith Humphreys
The American Journal of Psychiatry|February 2, 2002
Impaired recognition of facial emotion in maniaAnna Lembke, Terence A Ketter
Neuropsychiatric Disease and Treatment|March 21, 2009
Depression and smoking cessation: does the evidence support psychiatric practice?Anna Lembke, Kenasha Johnson, Charles DeBattista
American Family Physician|June 16, 2016
Weighing the Risks and Benefits of Chronic Opioid TherapyAnna Lembke, Keith Humphreys, Jordan Newmark
Journal of Addictive Diseases|March 30, 2021
Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case reportHuiqiong Deng, Ori-Michael Benhamou, Anna Lembke
Pageof 5